Latest eBooks

Download this eBook to explore a collection of news, articles, interviews and infographics published in 2021, handpicked by the publication’s editorial team.

Cell and gene therapies are continuing to gain popularity, with 15 now FDA approved and hundreds more in development. While these treatments are promising, managing safety and effectiveness in patients is complex.

Technological advances along with developments in molecular medicine and data science have fueled the exploration of personalized medicine, as a result, several fields are already benefiting. Download this eBook to learn more about the topic.

Cancer is reshaping our families, our communities and our world. It is among the leading causes of death globally and cancer rates are increasing for nearly every age group and indication. Despite its prevalence, there is so much left to reveal.

Download this eBook to learn more about the fight against infectious disease, bridging the gap between immune response and treatment development plus much more.

Every field of biology has a moonshot vision. Whether that be identifying a new cell type in a poorly characterized tissue, finding a lasting, effective drug target for Alzheimer’s disease or reaching 100% remission rates for immunotherapy across patients and cancer types.

Mycoplasma contamination of manufacturing cell cultures is rare, but presents a threat for biologics manufacturers. Traditionally, testing was done using a culture-based, 28-day mycoplasma test. More recently, PCR-based alternatives have evolved, driven by an industry move to shorten lot disposition cycles and the emergence of cell-based therapeutics that require a more rapid test.

Download this eBook to explore the new perspectives on single-cell analysis.

Download this eBook to discover an automated benchtop system that can be easily integrated into established workflows and allows you to design, engineer, evaluate and track editing results.

Download this eBook to learn more about the single cell and spatial technologies available for infectious disease research.